Secondary malignant neoplasms after Wilms tumor: An international collaborative study

International Journal of Cancer

Volumn 127, Issue 3, 2010, Pages 657-666

  Breslow, Norman E ^a,b   Lange, Jane M ^a   Friedman, Debra L ^c   Green, Daniel M ^d   Hawkins, Mike M ^e   Murphy, Michael F G ^f   Neglia, Joseph P ^g   Olsen, Jørgen H ^h   Peterson, Susan M ^b   Stiller, Charles A ^f   Robison, Leslie L ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Childhood cancer; Secondary malignant neoplasm; Wilms tumor

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; GEOGRAPHY; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NORTH AMERICA; PRIORITY JOURNAL; SCANDINAVIA; SECOND CANCER; SOLID TUMOR; SURVIVAL TIME; UNITED KINGDOM;

ADOLESCENT; CHILD; COHORT STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; NEOPLASMS, SECOND PRIMARY; SURVIVAL ANALYSIS; WILMS TUMOR;

EID: 77954454864     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25067     Document Type: Article

References (50)

1. Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumours. Br J Cancer 1990;62:1026-30.
2. D'Angio GJ. Oncology seen through the prism of Wilms' tumor. Med Pediatr Oncol 1985;13:53-8.
3. Rosoff PM. Focus on research: the two-edged sword of curing childhood cancer. N Engl J Med 2006;355:1522-3.
4. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant neoplasms following treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 1995;13:1851-9.
5. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 2001;93:618-29. (Pubitemid 32409629)
6. Taylor AJ, Winter DL, Pritchard-Jones K, Stiller CA, Frobisher C, Lancashire ER, Reulen RC, Hawkins MM. Second primary neoplasms in survivors of Wilms' tumour - a population-based cohort study from the British Childhood Cancer Survivor Study. Int J Cancer 2008;122:2085-93.
7. Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009;101:806-13.
8. D'Angio GJ, Evans AE, Breslow N, Beckwith B, Bishop H, Feigl P, Goodwin W, Leape LL, Sinks LF, Sutow W, Tefft M, Wolff J. The treatment of Wilms' tumor: results of the National Wilms' Tumor Study. Cancer 1976;38:633-46.
9. D'Angio GJ, Evans A, Breslow N, Beckwith B, Bishop H, Farewell V, Goodwin W, Leape L, Palmer N, Sinks L, Sutow W, Tefft M, et al. The treatment of Wilms' Tumor - results of the Second National Wilms' Tumor Study. Cancer 1981;47:2302-11. (Pubitemid 11098607)
10. D'Angio GJ, Breslow N, Beckwith B, Evans A, Baum E, deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P, Othersen B, Tefft M, et al. Treatment of Wilms' tumor: results of the Third National Wilms' Tumor Study. Cancer 1989;64:349-60.
11. Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy PE, Thomas PR, Kim T, Shochat SJ, Haase GM, Ritchey ML, Kelalis PP, D'Angio GJ. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1998;16:237-45.
12. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 2005;23:7312-21.
13. Evans AE, Norkool P, Evans I, Breslow N, D'Angio GJ. Late effects of treatment for Wilms' tumor. Cancer 1991;67:331-6.
14. Breslow N, Olshan A, Beckwith B, Moksness J, Feigl P, Green D. Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor. J Natl Cancer Inst 1994;86:49-51. (Pubitemid 24018384)
15. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, et al. Study design and cohort characteristics of the childhood cancer survivor study: a multi-institutional collaborative project. Med Pediatr Oncol 2002;38:229-39.
16. Stiller C. Childhood cancer in Britain: incidence, survival, mortality. Oxford: Oxford University Press, 2007. 270 p
17. Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, Stevens MC, Jenney M. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer 2008;50:1018-25.
18. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms' tumor: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
19. World Health Organization. International classification of diseases for oncology (ICD-O), 1st ed. Geneva: World Health Organization, 1976. 131 p
20. Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc B 2000;62:711-30.
21. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL. A methodological issue in the analysis of second-primary cancer incidence in longterm survivors of childhood cancers. Am J Epidemiol 2003;158:1108-13.
22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
23. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987. 406 p
24. Aalen O. Nonparametric inference for a family of counting processes. Ann Stat 1978;6:701-26.
25. Ramlau-Hansen H. Smoothing counting process intensities by means of kernel functions. Ann Stat 1983;11:453-66.
26. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972;135:185-206.
27. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B 1972;34:187-220.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
29. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Populations - Total U.S. (1969-2005) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released February 2008.
30. Pritchard-Jones K, Breslow NE. Wilms tumour and other childhood renal tumours. In: Eeles RA, Easton DF, Eng C, Ponder B, eds. Genetic predisposition to cancer, 2nd ed. London: Arnold, 2004. 119-31.
31. Huff V. Wilms tumor genetics: a new, unX-pected twist to the story. Cancer Cell 2007;11:105-7. (Pubitemid 46209857)
32. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, et al. Cancer survivorship - genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006;98:15-25.
33. Perilongo G, Felix CA, Meadows AT, Nowell P, Biegel J, Lange BJ. Sequential development of Wilms-tumor, T-cell acute lymphoblastic-leukemia, medulloblastoma and myeloid-leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case-report. Leukemia 1993;7:912-5. (Pubitemid 23210873)
34. Pritchard-Jones K, Renshaw J, King- Underwood L. The Wilms tumour (WT1) gene is mutated in a secondary leukemia in a WAGR patient. Hum Mol Genet 1994;3:1633-7. (Pubitemid 24295461)
35. Cherullo EE, Ross JH, Kay R, Novick AC. Renal neoplasms in adult survivors of childhood Wilms tumor. J Urol 2001;165:2013-6.
36. Kraushaar G, Wiebe S. Renal cell carcinoma as a second malignant neoplasm in a patient with nonsyndromic hemihypertrophy and previous Wilms tumor. Pediatr Radiol 2005;35:1208-11.
37. Tucker MA, D'Angio GJ, Boice JD, Jr, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, Hoover RN, Fraumeni JF, Jr. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987;317:588-93.
38. Tucker MA, Jones PH, Boice JD, Jr., Robison LL, Stone BJ, Stovall M, Jenkin RD, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8.
39. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-51.
40. Haddy N, Le Deley MC, Samand A, Diallo I, Guerin S, Guibout C, Oberlin O, Hawkins M, Zucker JM, de Vathaire F. Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood. Eur J Cancer 2006;42:2757-64.
41. Breslow N, Churchill G, Beckwith JB, Fernbach DJ, Otherson HB, Tefft M, D'Angio GJ. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis - results of the second National Wilms' Tumor Study. J Clin Oncol 1985;3:521-31. (Pubitemid 15111400)
42. Breslow NE, Churchill G, Nesmith BS, Thomas PR, Beckwith JB, Othersen HB, D'Angio GJ. Clinicopathologic features and prognosis for Wilms' tumor patients with metastases at diagnosis. Cancer 1986;58:2501-11.
43. Meadows AT. Curing cancer in children: minimizing price, maximizing value. J Clin Oncol 1995;13:1837-9.
44. Shearer P, Kapoor G, Beckwith JB, Takashima J, Breslow N, Green DM. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group. J Pediatr Hematol Oncol 2001;23:109-11.
45. Sandler ES, Friedman DJ, Mustafa MM, Winick NJ, Bowman WP, Buchanan GR. Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer 1997;79:1049-54.
46. Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, Chessells JM. Epipodophyllotoxins, alkylating-agents, and radiation and risk of secondary leukemia after childhood-cancer. Br Med J 1992;304:951-8.
47. Reinhard H, Semler O, Bürger D, Bode U, Flentje M, Göbel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter HG, Stöckle M, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiat 2004;216:132-40.
48. Tournade MF, Com-Nougué C, de Kraker J, Ludwig R, Rey A, Burgers JM, Sandstedt B, Godzinski J, Carli M, Potter R, Zucker JM; International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19:488-500.
49. Tournade MF, Com-Nougué C, Voûte P, Lemerle J, de Kraker J, Delemarre JF, Burgers M, Habrand JL, Moorman CGM, Bürger D, Rey A, Zucker JM, et al. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol 1993;11:1014-23.
50. Green DM. Controversies in the management of Wilms tumour - immediate nephrectomy or delayed nephrectomy? Eur J Cancer 2007;43:2453-6.